Last year marked the first time in Pfizer’s 175-year history that the drugmaker shelled out the requisite millions for ...
Pfizer expects full-year earnings in the range of $2.80 to $3 per share, with revenue in the range of $61 billion to $64 billion. This story was generated by Automated Insights ( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback